Open AccessMizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis
Author(s) -
Hidetoshi Kagawa,
Tsutomu Hiromasa,
Takayuki Hara,
Ayako Takaki,
Ryutaro Yamanaka,
Kenei Sada,
Hirofumi Makino
Publication year - 2012
Publication title -
clinical and experimental nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 50
eISSN - 1437-7799
pISSN - 1342-1751
DOI - 10.1007/s10157-012-0632-4
Subject(s) - mizoribine , medicine , lupus nephritis , tacrolimus , proteinuria , gastroenterology , nephrology , creatinine , systemic lupus erythematosus , rituximab , combination therapy , urology , cyclophosphamide , transplantation , kidney , chemotherapy , disease , lymphoma
Conventional cyclophosphamide-based treatment regimens for lupus nephritis (LN) are still not considered to be optimal. The aim of this study was to evaluate the efficacy and safety of mizoribine, tacrolimus, and corticosteroid combination therapy for LN.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom